Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Additional Effect of Hallux Valgus Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03468491
Recruitment Status : Unknown
Verified May 2018 by National Yang Ming University.
Recruitment status was:  Not yet recruiting
First Posted : March 16, 2018
Last Update Posted : June 1, 2018
Sponsor:
Information provided by (Responsible Party):
National Yang Ming University

Brief Summary:
The study purpose is to investigate the effectiveness of a program combining biomechanical taping with lower extremity neuromuscular exercises for runners with patellofemoral pain syndrome (PFPS) and hallux valgus

Condition or disease Intervention/treatment Phase
Patellofemoral Pain Syndrome Hallux Valgus Other: combined training Other: Proximal training Not Applicable

Detailed Description:
This will be a single-blind, experimental study with two treatment groups. A total of 30 college athletes with PFPS and hallux valgus and majoring in long distance running or soccer, or recreational runners in Taipei metropolitan area will be recruited. A set of clinical examination will be conducted to rule out abnormal knee structures, pathologies, or injuries apart from PFPS. The lower extremity alignment as well as hip and knee kinematics during a step down test will be tracked using Noraxon's myoMOTION system. Muscle activation of the muscles controlling the hip and knee movements during the step down test will be recorded using TELEmyo DTS of Noraxon. Hallux valgus angle will be measured with surface markers on photographs. Knee pain level will be rated in a visual analog scale. The investigators will analyze the data with Statistical Product and Service Solutions (SPSS) for Windows. Repeated-measure ANOVAs will be used to examine group-by-time interaction on all the outcome variables. All significance level will be set at 0.05.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Additional Effect of First Metatarsophalangeal Joint Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome
Estimated Study Start Date : June 20, 2018
Estimated Primary Completion Date : September 30, 2018
Estimated Study Completion Date : October 31, 2018

Resource links provided by the National Library of Medicine

MedlinePlus Genetics related topics: Bunion

Arm Intervention/treatment
Experimental: Combined training group
Biomechanical taping will first being applied to the participants of the combined training group. They will be asked to perform following exercises in this session afterwards. As the treatment session goes on, a set of foot intrinsic muscle strengthening exercise and lower extremity neuromuscular exercise will be provided.
Other: combined training
The whole intervention period will last for 6 weeks, 2 visits per week, 1 hour per visit in the Research Building Room 630 of National Yang Ming University. All programs will be under the supervision of a physiotherapist with 2-year experience individually. 1. Hallux valgus correction: 1.1 Joint alignment correction (Grade II joint mobilization, 10 times/set, 3 sets/visit) - 1st MTP joint distraction - Proximal talofibular joint anteroposterior glide - (Grade III joint mobilization if any restriction being found) 1.2 Biomechanical taping (using Dynamic taping, 1 time/ visit, keep the taping for 2 days minimum) 1.3 Foot intrinsic muscle strengthening (10 times/set for each exercise, 3 sets/visit): - Short foot exercise - Toespread out exercise - Heel-rise exercises 2. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 2.1 Single lunge 2.2 Stepping down 2.3 Vertical squat 2.4 Vertical jumping
Other Names:
  • hallux valgus correction
  • lower extremity neuromuscular exercises

Active Comparator: Proximal training group
For participants of the proximal training group, only a set of lower extremity neuromuscular exercise will be provided. This set of exercises is designed to be the same as for participants of combined training group.
Other: Proximal training
1. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 1.1 Single lunge 1.2 Stepping down 1.3 Vertical squat 1.4 Vertical jumping All exercises will first start on firm surface without additional resistance/weight. Later, settings will be gradually shifted into on firm surface with resisted band from random direction, on a cushion with/ without resisted band, on a BOSU balance trainer. Progression are made every 2 weeks ideally, while adjustments may be taken into concern due to individual differences.
Other Name: lower extremity neuromuscular exercises




Primary Outcome Measures :
  1. Displacement of femur in step-down test [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    displacement recorded in cm/BMI

  2. Displacement of tibia in step-down test [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    displacement recorded in cm/BMI

  3. Knee pain level [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    The level of knee pain during daily activities will be quantified with visual analogue scale.

  4. Changes of pain-free running distance [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    The changes of pain-free running distance will be recorded in kilometers.

  5. EMG amplitude of knee extensor [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    amplitude recorded in %MVC

  6. EMG amplitude of knee flexor [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    amplitude recorded in %MVC

  7. EMG amplitude of hip external rotator [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    amplitude recorded in %MVC

  8. changes of the muscle activation time between vastus medialis oblique and vastus lateralis [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    changes of the muscle activation time recorded in second


Secondary Outcome Measures :
  1. Tibiofemoral angle in relaxed standing [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    recorded in degree

  2. Hallux valgus angle in relaxed standing [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    recorded in degree

  3. Navicular drop [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    navicular position changes between sitting and relaxed standing, recording in cm

  4. Arch height index [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    arch height in one leg standing, recording in the ratio of arch height and truncated foot length

  5. Hip rotation angle in relaxed standing [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    recorded in degree

  6. Knee rotation angle in relaxed standing [ Time Frame: changes from baseline and after 6 weeks of intervention ]
    recorded in degree



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • High physical activity level (running at least 5 times/week and at least 2 hours/time)
  • Presenting anterior/retropatellar knee pain in the past 6 months
  • At least two of the following activities provocated symptom: Prolonged sitting, ascending and/or descending stairs, squatting, kneeling, running, limping
  • Not having any pathologies of knee joint (ligament tear, menisci injury, patellofemoral joint dislocation, tendinitis, bursitis…etc.)
  • With hallux valgus angle>15°
  • With 1st metatarsophalangeal joint instability
  • 20~40 y/o

Exclusion Criteria:

  • Lower extremities osteoarthritis
  • Systematic diseases such as rheumatoid arthritis, systemic lupus erythematosus, DM…etc.
  • Lower extremities fracture history
  • Surgical history of lower extremities
  • Neurological pathology that would interfere with gait
  • Hallux could not be corrected to neutral through passive correction
  • Low back pain and/or sacroiliac joint dysfunction in the past six months
  • Excessive femoral anteversion

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03468491


Contacts
Layout table for location contacts
Contact: Wen-Yin Chen, PhD +886 2826-7049 wychen@ym.edu.tw
Contact: Wan-Ling Yuan, BS +886 0935806408 be945a7ts@gmail.com

Sponsors and Collaborators
National Yang Ming University
Investigators
Layout table for investigator information
Study Director: be945a7ts@gmail.com Chen, PhD National Yang Ming University
Publications:
Layout table for additonal information
Responsible Party: National Yang Ming University
ClinicalTrials.gov Identifier: NCT03468491    
Other Study ID Numbers: YM106048F
First Posted: March 16, 2018    Key Record Dates
Last Update Posted: June 1, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Patellofemoral Pain Syndrome
Hallux Valgus
Syndrome
Somatoform Disorders
Disease
Pathologic Processes
Mental Disorders
Joint Diseases
Musculoskeletal Diseases
Foot Deformities